Fig. 4From: A genome-wide approach to link genotype to clinical outcome by utilizing next generation sequencing and gene chip data of 6,697 breast cancer patientsDistribution of significant hits in random analyses. To assess the expected false positive rate of the method, the entire pipeline was run 100 times each time on 100 randomly selected genes. The mean number of significant genes was 9.24, the number of significant genes was not more than 15 in any runBack to article page